Abiomed

After more than 25 years as a pioneer and global leader in the design and manufacture of heart assist and replacement devices, Abiomed was in need of a complete brand overhaul. Their technology had quickly outpaced their brand promise and visual identity. Vision was selected to create and execute the new brand in an all-encompassing initiative that included virtually every facet of Abiomed's business including marketing, sales, investor relations, professional education, as well as patient and clinician outreach.

In 2022, Abiomed was acquired by Johnson+Johnson for $16.6 billion.